Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.60
Bid: 12.60
Ask: 13.00
Change: -0.40 (-3.08%)
Spread: 0.40 (3.175%)
Open: 12.00
High: 12.60
Low: 12.00
Prev. Close: 13.00
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wipac Strategy Update

11 Jun 2019 07:00

RNS Number : 7458B
Carclo plc
11 June 2019
 

11 June 2019

 

Carclo plc ("Carclo" or the "Group")

 

Wipac Strategy Update

 

Carclo plc ("Carclo" or the "Group"), a global manufacturer of fine tolerance injection moulded plastic parts mainly for the medical, automotive lighting and optics markets, issues this strategy update ahead of the Group announcing its results, for the year-ended 31 March 2019, on 23 July.

 

Overall, Group performance in the first weeks of the current financial year, and Group net debt levels, have been broadly as anticipated. The Technical Plastics and Aerospace Divisions performed strongly but operating losses at Wipac, the main operating business in the Group's LED Technologies Division, have increased, with the business continuing to incur additional costs to meet growing customer demand.

 

In light of the ongoing challenges, and in order to establish a more sustainable platform for Wipac, the Board is reviewing the strategy for the business, in particular the move into the mid-volume vehicle market, which is placing significant strain on the Group. As part of this review, Wipac is working with its customers to develop a plan to refocus the operation on its historic low-volume vehicle markets where it had previously been financially successful. This plan might involve customers moving some programmes to alternative suppliers. Once implemented, the revised strategy is likely to have the effect of reducing Wipac's future sales revenue but would also, consequently, significantly reduce the Group's cash requirements for working capital and capital expenditure. The Board expects to be able to provide more detailed guidance on the financial implications of the revised strategy at the time of the full-year results announcement.

 

In the meantime, and as previously announced, discussions remain on going with the bank and other stakeholders in relation to the refinancing of the Group's borrowing facilities due to mature in March 2020. An interim Chief Restructuring Officer has been appointed to assist with these discussions.

 

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

 

Enquiries:

Carclo plc

01924 268040

Mark Rollins - Executive Chairman

Sarah Matthews De-Mers - Finance Director

FTI Consulting

020 3727 1340

Nick Hasell / Susanne Yule

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDURUKRKOANAAR
Date   Source Headline
10th Jul 20185:27 pmRNSForm 8.3 - [Carclo plc]
10th Jul 20184:10 pmRNSForm 8.3 - [carclo plc]
10th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
10th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
10th Jul 20189:57 amBUSForm 8.3 - Carclo PLC
9th Jul 20183:55 pmRNSForm 8.3 - Carclo plc
9th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
9th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
9th Jul 201810:39 amRNSForm 8.3 - Carclo plc
6th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
6th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
5th Jul 201812:09 pmRNSForm 8 (OPD) - CONSORT MEDICAL PLC
5th Jul 201812:08 pmRNSForm 8 (OPD) - Carclo plc
5th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
4th Jul 20183:04 pmRNSHolding(s) in Company
4th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
4th Jul 201810:26 amRNSForm 8.3 - Carclo plc
3rd Jul 20184:22 pmRNSForm 8.3 - Carclo Plc
3rd Jul 20182:33 pmPRNForm 8.3 - Carclo plc
3rd Jul 20182:26 pmRNSForm 8.3 - [Carclo plc]
3rd Jul 20181:56 pmRNSForm 8.3 - Carclo Plc
3rd Jul 20181:49 pmRNSHolding(s) in Company
3rd Jul 20181:32 pmRNSForm 8.3 - Carclo plc
3rd Jul 20181:00 pmRNSForm 8.3 - Carclo plc
3rd Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
3rd Jul 201811:36 amBUSForm 8.3 - Carclo plc - Ordinary shares
3rd Jul 201811:07 amRNSForm 8.3 - [Carclo plc]
2nd Jul 20181:07 pmRNSResponse to announcement from Consort Medical
2nd Jul 20187:00 amRNSNon-Binding Proposal for Carclo plc
28th Jun 20187:00 amRNSBoard changes
6th Jun 201810:27 amRNSHolding(s) in Company
5th Jun 20187:00 amRNSFinal Results
17th Apr 20187:00 amRNSDirectorate Change
9th Apr 20188:25 amRNSYear End Trading Update
26th Jan 20185:25 pmRNSDirector/PDMR Shareholding
24th Jan 201812:43 pmRNSDirector/PDMR Shareholding (Replacement)
24th Jan 201810:12 amRNSDirector/PDMR Shareholding
17th Jan 201811:27 amRNSHolding(s) in Company
16th Jan 201811:44 amRNSHolding(s) in Company
15th Jan 20187:00 amRNSTrading Update and Board Changes
12th Jan 20182:55 pmRNSHolding(s) in Company
12th Jan 20181:45 pmRNSHolding(s) in Company
10th Jan 20185:01 pmRNSHolding(s) in Company
28th Nov 20175:30 pmRNSHolding(s) in Company
14th Nov 20177:00 amRNSHalf-year Report
3rd Oct 20179:42 amEQSEdison Investment Research Limited: Edison issues outlook on Carclo (CAR)
26th Sep 20171:34 pmRNSDirectorate Change
21st Sep 20172:40 pmRNSHolding(s) in Company
8th Sep 201711:44 amRNSDirector/PDMR Shareholding
8th Sep 201711:40 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.